Shirin Rostami

Shirin Rostami

Auto-generated profile, based on publicly available information

Shirin Rostami

Department of Periodontics, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2025 in Journal of Advanced Periodontology & Implant Dentistry
Verified
Journal Article
Open access
PDF file
PBParichehr Behfarnia
Parichehr Behfarnia
RBReza Birang
Reza Birang
SRShirin Rostami
Shirin Rostami
VSVahid Sebghatollahi
Vahid Sebghatollahi
Background. This study aimed to assess the effectiveness of "a combined systemic and nonsurgical periodontal treatment" in eradicating gastric Helicobacter pylori in patients having the bacterium within their subgingival biofilm. Methods. This randomized clinical trial (RCT) investigated 102 patients diagnosed with peptic ulcer or dyspepsia and a positive stomach test for H. pylori infection (G+). Participants with a negative test for oral infection received only triple therapy (G3, n=38), and those positive for oral infection were randomly allocated to one of the two treatment regimens: a 14-day course of triple therapy (comprising antibiotics, antimicrobials, and proton pump inhibitors) alongside periodontal therapy (G1, n=32) or triple therapy alone (G2, n=32). The effectiveness of H. pylori eradication was assessed four weeks after treatment using the H. pylori stool antigen (stool Ag) test. Data analysis was performed using SPSS 22. Results. In the G2 and G3 groups, triple therapy achieved success rates of 52% and 84%, respectively. When periodontal therapy was integrated with triple therapy in the G1 group, the success rate was 80%. Significant differences were observed between the G1 and G2 groups (P=0.037) and also between the G3 and G2 groups (P=0.015). Conversely, no significant difference was found between the G1 and G3 groups (P>0.05). Conclusion. Periodontal therapy has the potential to substantially increase the efficacy of H. pylori eradication regimens for gastric infections.